Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New antiinflammatory agents prepared by Brazilian academics

Feb. 11, 1998

Idec evaluates humanized anti-gp39 antibody in phase I

Feb. 11, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Positive preclinical results reported for IPL-423

Feb. 10, 1998

Several related series of MMP inhibitors claimed by Bayer

Feb. 9, 1998

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

Phase III results reported for Prosorba

Jan. 30, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Boston Life Sciences to seek U.S. approval for Therafectin

Jan. 23, 1998

Inhibitors of prostaglandin biosynthesis prepared at Abbott

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...